SCHEMBL4030413

SCHEMBL4030413

O=C(c1ccc2c3c(ccc2c1)OCC3)c1c[nH]cn1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32
MAPT P10636 1/20 0.32
DRD2 P14416 4/20 0.31
HTR2A P28223 4/20 0.31
DRD3 P35462 4/20 0.31
LTC4S Q16873 1/20 0.31
MTNR1A P48039 1/20 0.31
MTNR1B P49286 1/20 0.31
CHEK2 O96017 1/20 0.30
IGFBP3 P17936 1/20 0.30
VNN1 O95497 1/20 0.30
CTNNB1 P35222 2/20 0.30
TSHR P16473 1/20 0.30
HDAC3 O15379 1/20 0.30
HDAC1 Q13547 1/20 0.30
HDAC2 Q92769 1/20 0.30
HDAC8 Q9BY41 1/20 0.30
HDAC6 Q9UBN7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4034041 0.93 NPC1 (0.36) NPC1RAB9ANPSR1MAPTMTNR1A
SCHEMBL4024487 0.81 PRKCI (0.35) NPC1RAB9AMAPTLTC4SCTNNB1
SCHEMBL4024232 0.73 CTNNB1 (0.33) RAB9AMAPTHTR2AIGFBP3CTNNB1
SCHEMBL4023986 0.72 VNN1 (0.36) NPC1RAB9ANPSR1MAPTDRD2
SCHEMBL5750943 0.72 MEN1 (0.51) NPC1RAB9AMAPTCHEK2IGFBP3
SCHEMBL4033868 0.72 CYP17A1 (0.32) NPC1MAPT
SCHEMBL5752322 0.69 L3MBTL1 (0.41) RAB9AIGFBP3TSHR
SCHEMBL4027318 0.69 MTNR1A (0.30) MTNR1AMTNR1B
SCHEMBL4027830 0.69 CYP17A1 (0.41)
SCHEMBL5678286 0.68 KDM4E (0.53) NPC1NPSR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1222174-B1 IMIDAZOL-4-YLMETHANOLS USED AS INHIBITORS OF STEROID C17-20 LYASE TAKEDA PHARMACEUTICAL (JP) 2009-05-27 EP disclosed
US-6649643-B1 Antitumor, anticarcinogenic, and antimetastasis agents; benign prostatic hyperplasia, alopecia, endometriosis, uterine myoma, hirsutism, virilism, precocious puberty, mastopathy, and polycystic overay syndrome treatment TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-11-18 US disclosed
EP-1222174-A1 IMIDAZOL-4-YLMETHANOLS USED AS INHIBITORS OF STEROID C17-20 LYASE Takeda Chemical Industries, Ltd. (JP) 2002-07-17 EP disclosed
WO-2001030762-A1 IMIDAZOL-4-YLMETHANOLS USE AS INHIBITORS OF STEROID C17-20 LYASE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-05-03 WO disclosed